{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:09:01Z","timestamp":1790532541952,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/mpa.0b013e318273096c","type":"journal-article","created":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T00:27:42Z","timestamp":1356740862000},"page":"622-632","source":"Crossref","is-referenced-by-count":16,"title":["Usefulness of MALDI-TOF\/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer"],"prefix":"10.1097","volume":"42","author":[{"given":"Andrea","family":"Padoan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Seraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fogar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Sperti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Moz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Marchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"de Manzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo-Federico","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Navaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cristadoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda","family":"Di Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Nitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pedrazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolamo","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210212","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejso.2006.10.004","article-title":"Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer.","volume":"33","author":"Goonetilleke","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"R2-10-20210212","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00432-010-0965-x","article-title":"Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.","volume":"137","author":"Bunger","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"R3-10-20210212","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-10-20210212","first-page":"44","article-title":"Current status of molecular markers for early detection of sporadic pancreatic cancer.","volume":"1815","author":"Chakraborty","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R5-10-20210212","first-page":"339","article-title":"Diabetes and pancreatic cancer: chicken or egg Pancreas.","volume":"40","author":"Magruder","year":"2011","journal-title":""},{"key":"R6-10-20210212","first-page":"2827","article-title":"Diabetes mellitus in pancreatic cancer follow-up.","volume":"14","author":"Fogar","year":"1994","journal-title":"Anticancer Res"},{"key":"R7-10-20210212","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","article-title":"Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus.","volume":"134","author":"Pannala","year":"2008","journal-title":"Gastroenterology"},{"key":"R8-10-20210212","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jcp.22355","article-title":"Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (NT-S100A8).","volume":"226","author":"Basso","year":"2011","journal-title":"J Cell Physiol"},{"key":"R9-10-20210212","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/cncr.10493","article-title":"A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus.","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"R10-10-20210212","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejca.2010.07.010","article-title":"The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.","volume":"47","author":"Ben","year":"2011","journal-title":"Eur J Cancer"},{"key":"R11-10-20210212","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1470-2045(08)70337-1","article-title":"New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer.","volume":"10","author":"Pannala","year":"2009","journal-title":"Lancet Oncol"},{"key":"R12-10-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MAJ.0b013e3181f0e2a0","article-title":"CA 19-9 level in patients with type 2 diabetes mellitus and its relation to the metabolic control and microvascular complications.","volume":"341","author":"Gul","year":"2011","journal-title":"Am J Med Sci"},{"key":"R13-10-20210212","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/pr100532g","article-title":"Evolution of clinical proteomics and its role in medicine.","volume":"10","author":"Boja","year":"2011","journal-title":"J Proteome Res"},{"key":"R14-10-20210212","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/rcm.528","article-title":"Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern.","volume":"15","author":"Valerio","year":"2001","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R15-10-20210212","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/1078-0432.CCR-1167-3","article-title":"Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry.","volume":"10","author":"Koopmann","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R16-10-20210212","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1158\/0008-5472.CAN-05-1851","article-title":"Possible detection of pancreatic cancer by plasma protein profiling.","volume":"65","author":"Honda","year":"2005","journal-title":"Cancer Res"},{"key":"R17-10-20210212","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s11605-008-0632-6","article-title":"Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer.","volume":"12","author":"Kojima","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R18-10-20210212","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1078-0432.1110.11.3","article-title":"Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins.","volume":"11","author":"Koomen","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R19-10-20210212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000084824","article-title":"Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorptionionization-based decision tree classification.","volume":"68","author":"Yu","year":"2005","journal-title":"Oncology"},{"key":"R20-10-20210212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/mpa.0b013e3180d0a738","article-title":"Biomarker identification in human pancreatic cancer sera.","volume":"36","author":"Hanas","year":"2008","journal-title":"Pancreas"},{"key":"R21-10-20210212","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1515\/CCLM.2009.158","article-title":"Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.","volume":"47","author":"Navaglia","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"R22-10-20210212","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/MPA.0b013e3181dfcbe5","article-title":"Standardized peptidome profiling of human serum for the detection of pancreatic cancer.","volume":"39","author":"Zapico-Muniz","year":"2010","journal-title":"Pancreas"},{"key":"R23-10-20210212","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjc.6605764","article-title":"Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.","volume":"103","author":"Xue","year":"2010","journal-title":"Br J Cancer"},{"issue":"suppl 1","key":"R24-10-20210212","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"R25-10-20210212","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1471-2334-10-364","article-title":"UK Etiology of Encephalitis Study Group. Cluster analysis for identifying sub-groups and selecting potential discriminatory variables in human encephalitis.","volume":"10","author":"Hamid","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R27-10-20210212","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jcla.20134","article-title":"Reference distributions for apolipoproteins AI and B and the apolipoprotein BAI ratios: a practical and clinical relevant approach in a large cohort.","volume":"20","author":"Ritchie","year":"2006","journal-title":"J Clin Lab Anal"},{"key":"R28-10-20210212","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1200\/JCO.2009.25.6065","article-title":"Sources of bias in specimens for research about molecular markers for cancer.","volume":"28","author":"Ransohoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"R29-10-20210212","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.dld.2008.07.316","article-title":"Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients.","volume":"41","author":"Frulloni","year":"2009","journal-title":"Dig Liver Dis"},{"key":"R30-10-20210212","first-page":"298","article-title":"Pancreatic cancer. N Engl J Med. 2010; 362: 1605-1617.","volume":"3","author":"Hidalgo","year":"2010","journal-title":"Erratum in: N Engl J Med"},{"key":"R31-10-20210212","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000140961","article-title":"Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma.","volume":"25","author":"Smith","year":"2008","journal-title":"Dig Surg"},{"key":"R32-10-20210212","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1021\/pr800451h","article-title":"Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer.","volume":"8","author":"Yan","year":"2009","journal-title":"J Proteome Res"},{"key":"R33-10-20210212","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/CJI.0b013e3181bed29f","article-title":"Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology.","volume":"33","author":"Marten","year":"2010","journal-title":"J Immunother"},{"key":"R34-10-20210212","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/ERC-09-0140","article-title":"The clusterin paradigm in prostate and breast carcinogenesis.","volume":"17","author":"Rizzi","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"R35-10-20210212","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/1078-0432.CCR-10-0248","article-title":"Serum biomarker panels for the detection of pancreatic cancer.","volume":"15","author":"Brand","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R36-10-20210212","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-5956-9-21","article-title":"Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma.","volume":"9","author":"Li","year":"2011","journal-title":"Proteome Sci"},{"key":"R37-10-20210212","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mpa.0000250128.57026.b2","article-title":"Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.","volume":"34","author":"Ehmann","year":"2007","journal-title":"Pancreas"},{"key":"R38-10-20210212","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/gut.2010.225011","article-title":"Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition.","volume":"60","author":"van Duijnhoven","year":"2011","journal-title":"Gut"},{"key":"R39-10-20210212","doi-asserted-by":"crossref","first-page":"19997","DOI":"10.1073\/pnas.1009010107","article-title":"Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.","volume":"107","author":"Su","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-10-20210212","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1039\/c0ib00147c","article-title":"L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGFbasic FGF signaling pathways.","volume":"3","author":"Gao","year":"2011","journal-title":"Integr Biol"},{"key":"R41-10-20210212","doi-asserted-by":"crossref","first-page":"18959","DOI":"10.1074\/jbc.273.30.18959","article-title":"Effects of glucose and insulin on rat apolipoprotein A-I gene expression.","volume":"273","author":"Murao","year":"1998","journal-title":"J Biol Chem"},{"key":"R42-10-20210212","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1002\/pmic.201000827","article-title":"Identification of blood-protein carriers of the Ca 19-9 antigen and characterization of prevalence in pancreatic disease.","volume":"11","author":"Yue","year":"2011","journal-title":"Proteomics"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0b013e318273096c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T07:25:58Z","timestamp":1687937158000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201305000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e318273096c","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}